EyePoint Pharmaceuticals

Content by EyePoint Pharmaceuticals:

Articles

Subspecialties Cataract

DEXYCU: Jason Bacharach

12/09/2019 | Sponsored by EyePoint Pharmaceuticals

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

DEXYCU: Mark Pyfer

12/06/2019 | Sponsored by EyePoint Pharmaceuticals

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

DEXYCU: Michael Savetsky

11/21/2019 | Sponsored by EyePoint Pharmaceuticals

Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Ophthalmologist magazine

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: